Clinical Trial

Left Bundle Branch Area Pacing Using Conventional Stylet-driven Pacemaker Leads for Cardiac Resynchronization Therapy

Study acronym: LeCaRT
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 23, 2024 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study proposal is to compare the effectiveness of two distinct pacing modalities for cardiac resynchronization therapy. Our primary hypothesis is that left bundle branch area pacing (LBBAP) using conventional stylet driven pacemaker leads is an effective resynchronization method that yield to at least similar clinical benefits and outcomes when compare to biventricular pacing.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-05-06; most recent amendment 2024-09-20.
Status change: Recruiting → Active, Not Recruiting 2024-09-20
Status change: Not Yet Recruiting → Recruiting 2022-10-07
Trial Details
NCT Number NCT05365568
Lead Sponsor AZ Sint-Jan AV
Conditions Heart Failure with Reduced Ejection Fraction
Enrollment 170 participants
Start Date 2022-09-01
Primary Completion 2025-09-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2024-09-23